Boehringer Ingelheim Animal Health Usa competitive analysis

Explore patent oppositions filed by Boehringer Ingelheim Animal Health Usa against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jun 25, 2026
Patent NumberTitleApplicantOpposition Date
New Phosphonated Non-Fluorinated And Partially Fluorinated Aryl Polymers From Sulfonated Aryl Polymers And New Polymeric Perfluorophosphonic Acids From Perfluorosulfonic Acids, Their Process Of Preparation And Use In Electromembrane ApplicationsRIVA POWER SYSTEMSSep 18, 2025
Process For Manufacturing Chewable Dosage Forms For Drug Delivery And Products ThereofBAYERJun 22, 2021
Controlled Release Compositions And Their Methods Of UseBAYERFeb 19, 2020
One Dose Vaccination With Mycoplasma HyopneumoniaeZOETIS PJan 3, 2020
Recombinant Marek'S Disease Viruses And Uses ThereofCEVA SANT ANIMALEDec 24, 2019
Compositions For Treating Heartworm InfestationCEVA SANT ANIMALESep 25, 2019
Spot-On Pesticide CompositionSERGEANTS PET CARE PRODUCTSJul 22, 2019
Recombinant Non-Pathogenic Marek'S Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus And Newcastle Disease Virus AntigensINTERVETJul 9, 2019
Pcv/Mycoplasma Hyopneumoniae Combination VaccineZOETISApr 4, 2019
Pcv/Mycoplasma Hyopneumoniae/Prrs Combination VaccineZOETISFeb 7, 2019

Explore Boehringer Ingelheim Animal Health Usa's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 25, 2026
Patent NumberPublication DateTitleTotal Oppositions
May 13, 2026Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions1
Jan 28, 2026Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs1
Oct 26, 2022Porcine Circovirus Type 2 (Pcv2) Subunit Vaccine2
Oct 26, 2022Recombinant Hvt Vectors Expressing Multiple Antigens Of Avian Pathogens, And Vaccines Comprising Them2
Aug 17, 2022Recombinant Gallid Herpesvirus 3 (Mdv Serotype 2) Vectors Expressing Antigens Of Avian Pathogens And Uses Thereof1
Nov 3, 2021Newcastle Disease Virus Vectored Avian Vaccines1
Mar 10, 2021Parasiticidal Oral Veterinary Compositions Comprising Systemically-Acting Active Agents, Methods And Uses Thereof2
Mar 3, 2021Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Them3
Jul 29, 2020Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs3
May 27, 2020Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions2

Latest PTAB cases involving Boehringer Ingelheim Animal Health Usa

Discover the latest PTAB cases involving Boehringer Ingelheim Animal Health Usa, highlighting their recent legal challenges and patent disputes.

Last updated on: Jun 29, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Boehringer Ingelheim Animal Health Usa

PGR2022-00021Dec 22, 2021BOEHRINGER INGELHEIM ANIMAL HEALTH USAKANSAS STATE UNIVERSITY RESEARCH FOUNDATIONInstitution Denied
PGR2022-00021Dec 22, 2021HRINGKANSAS STATE UNIVERSITY RESEARCH FOUNDATIONInstitution Denied
PGR2020-00076Jul 22, 2020BOEHRINGER INGELHEIM ANIMAL HEALTH USAKANSAS STATE UNIVERSITY RESEARCH FOUNDATIONFinal Written Decision
PGR2020-00076Jul 22, 2020HRINGKANSAS STATE UNIVERSITY RESEARCH FOUNDATIONFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Boehringer Ingelheim Animal Health Usa with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jun 25, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
HRING17332 -
CEVA SANTE ANIMALE236 - -
INTERVET125041
LABORATORIOS HIPRA9 - - -